TET2-driven demethylation of ANG promotes angiogenesis and malignant transformation in oligodendroglioma

Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer. 1997;79:1381–93.

Article 
CAS 
PubMed 

Google Scholar 

Bready D, Placantonakis DG. Molecular pathogenesis of low-grade glioma. Neurosurg Clin North Am. 2019;30:17–25.

Article 

Google Scholar 

Bromberg JE, van den Bent MJ. Oligodendrogliomas: molecular biology and treatment. oncologist. 2009;14:155–63.

Article 
CAS 
PubMed 

Google Scholar 

Wang TJC, Mehta MP. Low-grade glioma radiotherapy treatment and trials. Neurosurg Clin North Am. 2019;30:111–8.

Article 
CAS 

Google Scholar 

Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182–6.

Article 
CAS 
PubMed 

Google Scholar 

Qi L, Wang ZY, Shao XR, Li M, Chen SN, Liu XQ, et al. ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma. Oncogene. 2020;39:5964–78.

Article 
CAS 
PubMed 

Google Scholar 

Guarnaccia L, Navone SE, Trombetta E, Cordiglieri C, Cherubini A, Crisà FM, et al. Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy. Sci Rep. 2018;8:8748.

Article 
PubMed 
PubMed Central 

Google Scholar 

Reyes-Botero G, Dehais C, Idbaih A, Martin-Duverneuil N, Lahutte M, Carpentier C, et al. Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Neuro-Oncology. 2014;16:662–70.

Article 
CAS 
PubMed 

Google Scholar 

Sampath P, Weaver CE, Sungarian A, Cortez S, Alderson L, Stopa EG. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma. Cancer Control. 2004;11:174–80.

Article 
PubMed 

Google Scholar 

Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia. 1995;15:339–47.

Article 
CAS 
PubMed 

Google Scholar 

Hoang TT, Raines RT. Molecular basis for the autonomous promotion of cell proliferation by angiogenin. Nucleic acids Res. 2017;45:818–31.

Article 
CAS 
PubMed 

Google Scholar 

Hu JL, Luo WJ, Wang H. Angiogenin upregulation independently predicts unfavorable overall survival in proneural subtype of glioblastoma. Technol Cancer Res Treat. 2019;18:1533033819846636.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Rozman A, Silar M, Kosnik M. Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients. Radiol Oncol. 2012;46:354–9.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Vanli N, Guo-Fu HU. Mechanism and function of angiogenin in prostate cancer. Zhongguo sheng wu hua xue yu fen zi sheng wu xue bao = Chin J Biochem Mol Biol. 2015;31:1261–6.

CAS 

Google Scholar 

Raghu H, Lakka SS, Gondi CS, Mohanam S, Dinh DH, Gujrati M, et al. Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines. PloS ONE. 2010;5:e12458.

Article 
PubMed 
PubMed Central 

Google Scholar 

Xia W, Fu W, Cai X, Wang M, Chen H, Xing W, et al. Angiogenin promotes U87MG cell proliferation by activating NF-κB signaling pathway and downregulating its binding partner FHL3. PloS ONE. 2015;10:e0116983.

Article 
PubMed 
PubMed Central 

Google Scholar 

Chen LL, Morcelle C, Cheng ZL, Chen X, Xu Y, Gao Y, et al. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses. Nat Cell Biol. 2022;24:353–63.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Jung I, An J, Ko M. Epigenetic regulators of DNA cytosine modification: promising targets for cancer therapy. Biomedicines. 2023;11:654.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Liu C, Tang H, Hu N, Li T. Methylomics and cancer: the current state of methylation profiling and marker development for clinical care. Cancer Cell Int. 2023;23:242.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Madala HR, Punganuru SR, Arutla V, Misra S, Thomas TJ, Srivenugopal KS. Beyond brooding on oncometabolic Havoc in IDH-mutant gliomas and AML: current and future therapeutic strategies. Cancers. 2018;10:49.

Article 
PubMed 
PubMed Central 

Google Scholar 

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462:739–44.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, et al. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proc Natl Acad Sci USA. 2017;114:10743–8.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar